Holdings of Lannebo Hälsa och Ny Teknik
Lannebo Kapitalförvaltning AB ·40 declared positions · as of Mar 31, 2026
Original filing · Net assets 360.8M SEK · Ten largest lines: 48.4 % of the equity sleeve
Sector breakdown
- Health care 1.6 %
- Unattributed 98.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- SEK 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- SE 72.0 %
- DK 11.2 %
- US 8.6 %
- NO 7.0 %
- GB 1.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | SE | 23 | 258.1M SEK | 72.05 % |
| 2 | DK | 7 | 40.1M SEK | 11.20 % |
| 3 | US | 5 | 31M SEK | 8.65 % |
| 4 | NO | 4 | 25.2M SEK | 7.03 % |
| 5 | GB | 1 | 3.9M SEK | 1.08 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | RaySearch Laboratories AB | 110,535 | 21.2M SEK | 5.86 % |
| 2 | BoneSupport Holding AB | 103,162 | 20.1M SEK | 5.57 % |
| 3 | Carasent AB | 874,956 | 20.1M SEK | 5.56 % |
| 4 | Xvivo Perfusion AB | 83,192 | 19.1M SEK | 5.28 % |
| 5 | Dynavox Group AB | 211,645 | 18.5M SEK | 5.13 % |
| 6 | Elekta AB | 285,837 | 15.8M SEK | 4.37 % |
| 7 | ALK-Abello A/S | 52,943 | 15.7M SEK | 4.36 % |
| 8 | Cellavision AB | 98,705 | 15.2M SEK | 4.20 % |
| 9 | Genovis AB | 833,508 | 15.1M SEK | 4.17 % |
| 10 | Swedish Orphan Biovitrum AB | 32,316 | 12.7M SEK | 3.51 % |
| 11 | Sectra AB | 49,364 | 11.2M SEK | 3.09 % |
| 12 | GN Store Nord AS | 75,180 | 11.1M SEK | 3.09 % |
| 13 | Terns Pharmaceuticals Inc | 22,152 | 11.1M SEK | 3.08 % |
| 14 | Devyser Diagnostics AB | 146,206 | 11.1M SEK | 3.07 % |
| 15 | Camurus AB | 23,433 | 10.9M SEK | 3.03 % |
| 16 | AddLife AB | 78,068 | 10.9M SEK | 3.02 % |
| 17 | Scholar Rock Holding Corp | 22,136 | 10.4M SEK | 2.87 % |
| 18 | Nordic Semiconductor ASA | 69,239 | 10.4M SEK | 2.87 % |
| 19 | Sedana Medical AB | 903,029 | 8.3M SEK | 2.31 % |
| 20 | Egetis Therapeutics AB (publ) | 1,399,908 | 7.7M SEK | 2.13 % |
| 21 | PAXMAN | 156,812 | 7.5M SEK | 2.09 % |
| 22 | Getinge AB | 37,881 | 7.1M SEK | 1.98 % |
| 23 | BICO Group AB | 421,070 | 7M SEK | 1.95 % |
| 24 | Medicover AB | 35,800 | 6.7M SEK | 1.87 % |
| 25 | Chemometec A/S | 15,054 | 6.7M SEK | 1.84 % |
| 26 | GENTIAN DIAGNOSTICS | 154,338 | 5.8M SEK | 1.59 % |
| 27 | ArcticZymes Technologies ASA | 259,047 | 4.9M SEK | 1.37 % |
| 28 | Senzime AB (publ) | 1,057,233 | 4.4M SEK | 1.23 % |
| 29 | Medistim ASA | 20,023 | 4.1M SEK | 1.15 % |
| 30 | AstraZeneca PLC | 2,081 | 3.9M SEK | 1.07 % |
| 31 | Viking Therapeutics Inc | 12,116 | 3.8M SEK | 1.04 % |
| 32 | Rhythm Pharmaceuticals Inc | 4,409 | 3.7M SEK | 1.01 % |
| 33 | BioInvent International AB | 161,507 | 3.6M SEK | 1.00 % |
| 34 | BioArctic AB | 8,001 | 2.6M SEK | 0.71 % |
| 35 | Zealand Pharma A/S | 5,171 | 2.2M SEK | 0.62 % |
| 36 | H Lundbeck A/S | 37,722 | 2.2M SEK | 0.61 % |
| 37 | Structure Therapeutics Inc | 4,518 | 2.1M SEK | 0.57 % |
| 38 | Novo Nordisk A/S | 5,356 | 1.8M SEK | 0.50 % |
| 39 | Orexo AB | 65,413 | 1.4M SEK | 0.40 % |
| 40 | Ambu A/S | 3,575 | 359.2K SEK | 0.10 % |